COMPARATIVE STUDIES OF EFFICACY AND EFFECTS ON OXIDATIVE STRESS OF AMLODIPINE AND RAMIPRIL IN THE HYPERTENSIVE PATIENTS OF NORTH EAST INDIA
Objective: To compare the efficacy and the effect of the oxidative stress of Calcium Channel Blocker (CCB), Amlodipine and Angiotensin Converting Enzyme (ACE) inhibitor, Ramipril in the hypertensive patients of North East India.
Methods: It is a prospective randomized controlled parallel study of the clinically used antihypertensive drug. Total 75 subjects were included in the study. Out of 75 subjects, 25 numbers were normal healthy subjects and remaining 50 were hypertensive patients. The patients were randomized and divided into two groups; Amlodipine treated group (n=25) and Ramipril treated group (n=25). Amlodipine group received Amlodipine (5-10) mg/day and Ramipril group received Ramipril daily (5-10) mg. All patients were newly detected hypertensive subjects suffering from essential hypertension without any prior antihypertensive therapy. Patients included were either sex (male/female) in age group of 20-65 y with normal fasting blood sugar level (FBS) and free from any other diseases. All groups was subjected to measurement of blood pressure, estimation of blood parameters like FBS, serum lipid profiles, serum glutamate pyruvate transaminase (SGPT) and serum glutamate oxaloacetate (SGOT) before antihypertensive treatment. The height, age, weight, health status and lifestyle pattern of patients were recorded. The patients were followed up during 8 w of antihypertensive treatment. Serum levels of glutathione (GSH), total antioxidant (TAS), superoxide dismutase (SOD) and malondialdehyde (MDA) levels were estimated before and after 8 w of antihypertensive therapy.
Results: The present study indicated that both amlodipine and ramipril have significant effects on normalizing systolic and diastolic blood pressure (BP) after 8 w of treatment. Ramipril significantly reduced malondialdehyde (MDA) level and increased the serum levels of GSH, TAS and SOD during antihypertensive treatment. Ramipril reduces oxidative stress because of its antioxidant activity during antihypertensive therapy.
Conclusion: Amlodipine and Ramipril are effective antihypertensive drugs. ACE inhibitor (Ramipril) has additional benefit of reducing oxidative stress thereby restoring the endothelial dysfunction in the hypertensive patient.
2. Kearney PM, Whelton M, Regardh CG. Global burden of hypertension, analysis of worldwide data. Lancet 2005;365:217-23.
3. Lawes CM, Rodegers A, Benneyt DA. Blood pressure and cardio vascular disease in the different regions. J Hypertens 2003;21:707-16.
4. Mulvany MJ. Small artery remodeling in hypertension. Curr Hypertens Rep 2002;4:49-55.
5. Xia Y, Dawson VL, Snyder S, Zweier JL. Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury. Proc Natl Acad Sci USA 1996;93:6770-74.
6. Simon G. Pathogenesis of structural vascular changes in hypertension. J Hypertens 2004;22:3-10.
7. Hazarika NC, Narain K, Biswas D. Hypertension in the rural native population of Assam. Natl Med J India 2004;17:300-4.
8. Shah A, Afzal M. Prevalence of diabetes and hypertension and association with various risk factors among different Muslim populations of Manipur. India J Diabetes Metab Disorders 2013;12:52.
9. Naidu MS, Suryakar AN, Swami SC, Katkam RV, Kumbar KM. These pathological proceses: oxidative stresses and antioxidant status in cervical cancer patients. Indian J Clin Biochem 2007;22:140-4.
10. Misra HP, Fridowich J. Superoxide dismutase: a photochemical augmentation assay. Arch Biochem Biophys 1997;181:303-12.
11. Arutla, Chinnappa MP, Devarakonda RK. Pro and antioxidant effect of some antileprotic drug in vitro and their influence on superoxide dismutase activity. Drug Res 1998;48:1024-7.
12. Beulter E, Duron O, Kelly BM. An improved method for the determination of blood glutathione. J Lab Clin Med 1963;61:882-8.
13. Blios MS. Antioxidant determination by the use of stable free radical. Nature 1958;26:1199.
14. Moore K, Robert IJ. Measurement of lipid peroxidation. Free Radical Res 1998;28:659-71.
15. Reitman S, Frankel S. A colorimetric method for the determination of serum glutamic oxaloacetic and glutamic pyruvate transaminases. Am J Clin Pathol 1957;28:56-63.
16. Touzy RM. Oxidative stress and vascular damage in hypertension. Hypertens Rep 2000;2:96-105.
17. Ferrira I, Twisk JW, Mechelen W Van. Development of fatness, fitness and lifestyle from adolescence to the age of 65 y. Arch Intern Med 2005;165:42-8.
18. Verbeelam DL, Craemer DD. Enalapril increases antioxidant enzyme activity in renal cortical tissues. Nephron 1998;80:214-9.
19. Sebekova K, Hcidland A. Effect of ramipril in nondiabetic nephropathy: Improved parameter of oxidative Stress. J Hypertens 2003;17:265-70.
20. Solzbach U, Harning B, Jeserich M, Just H. Vitamin C improve endothelial dysfunction of epicardial coronary arteries in hypertensive patients. Circulation 1997;96:1513-9.
21. Gillis CN, Chen X, Merker MM. Lisinopril and ramiprilate protection of vascular endothelium against free radical induced functional injury. J Pharmacol Exp Ther 1992;262:212-6.
22. Authur JR. The glutathione peroxidase. Cell Mol Life Sci 2000;57:1825-35.
23. Sies H. Glutathione and its role in cellular functions. Free Radical Biol Med 1999;27:916-21.